BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 22192811)

  • 1. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
    Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
    Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a PET radioligand selective for cerebral amyloid angiopathy.
    Abrahamson EE; Stehouwer JS; Vazquez AL; Huang GF; Mason NS; Lopresti BJ; Klunk WE; Mathis CA; Ikonomovic MD
    Nucl Med Biol; 2021 Jan; 92():85-96. PubMed ID: 32471773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy.
    Jia J; Cui M; Dai J; Liu B
    Mol Pharm; 2015 Aug; 12(8):2937-46. PubMed ID: 26065726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.
    Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX
    Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.
    Robbins EM; Betensky RA; Domnitz SB; Purcell SM; Garcia-Alloza M; Greenberg C; Rebeck GW; Hyman BT; Greenberg SM; Frosch MP; Bacskai BJ
    J Neurosci; 2006 Jan; 26(2):365-71. PubMed ID: 16407531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
    Han BH; Zhou ML; Abousaleh F; Brendza RP; Dietrich HH; Koenigsknecht-Talboo J; Cirrito JR; Milner E; Holtzman DM; Zipfel GJ
    J Neurosci; 2008 Dec; 28(50):13542-50. PubMed ID: 19074028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
    Xiong M; Wang C; Gratuze M; Saadi F; Bao X; Bosch ME; Lee C; Jiang H; Serrano JR; Gonzales ER; Kipnis M; Holtzman DM
    Mol Neurodegener; 2023 Mar; 18(1):17. PubMed ID: 36922879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
    Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
    J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
    Haglund M; Kalaria R; Slade JY; Englund E
    Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
    Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
    Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal.
    McCarter SJ; Lesnick TG; Lowe V; Mielke MM; Constantopoulos E; Rabinstein AA; Przybelski SA; Botha H; Jones DT; Ramanan VK; Jack CR; Petersen RC; Knopman D; Boeve BF; Murray ME; Dickson DW; Vemuri P; Kantarci K; Reichard RR; Graff-Radford J
    Neurology; 2021 Nov; 97(18):e1799-e1808. PubMed ID: 34504022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with five vascular risk factors causes cerebral amyloid angiopathy but no Alzheimer pathology in C57BL6 mice.
    Foidl BM; Humpel C
    Brain Behav Immun; 2019 May; 78():52-64. PubMed ID: 30664922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.
    Savastano A; Klafki H; Haußmann U; Oberstein TJ; Muller P; Wirths O; Wiltfang J; Bayer TA
    J Alzheimers Dis; 2016; 49(1):101-10. PubMed ID: 26529393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias.
    Michno W; Koutarapu S; Camacho R; Toomey C; Stringer K; Minta K; Ge J; Jha D; Fernandez-Rodriguez J; Brinkmalm G; Zetterberg H; Blennow K; Ryan NS; Lashley T; Hanrieder J
    J Neurochem; 2022 Nov; 163(3):233-246. PubMed ID: 36102248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease.
    Boon BDC; Bulk M; Jonker AJ; Morrema THJ; van den Berg E; Popovic M; Walter J; Kumar S; van der Lee SJ; Holstege H; Zhu X; Van Nostrand WE; Natté R; van der Weerd L; Bouwman FH; van de Berg WDJ; Rozemuller AJM; Hoozemans JJM
    Acta Neuropathol; 2020 Dec; 140(6):811-830. PubMed ID: 32926214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques.
    Zhu X; Victor TW; Ambi A; Sullivan JK; Hatfield J; Xu F; Miller LM; Van Nostrand WE
    Metallomics; 2020 Apr; 12(4):539-546. PubMed ID: 32104807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.